PUBLISHER: Grand View Research | PRODUCT CODE: 1611250
PUBLISHER: Grand View Research | PRODUCT CODE: 1611250
The global bipolar forceps market size is estimated to reach USD 1.30 billion by 2030, registering a CAGR of 5.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of chronic conditions, an increasing number of minimally invasive procedures, and the high volume of product launches are the factors augmenting the market. For instance, in November 2016, HOYA Group PENTAX Medical launched the bipolar hot hemostasis forceps - HemoStat WideCup at the JDDW 2016 Congress, Japan. The new device allows for easy bleeding control during endoscopic procedures. Such procedures have gained global interest, as they offer substantial clinical and financial benefits, resulting in reduced procedural complexities, early recovery, and costs.
The usage of bipolar forceps is expected to soar over the forecast period due to the increasing number of neurology and plastic surgeries. According to the American Association of Neurological Surgeons, 2017, an estimated 22.6 million patients suffer from neurological conditions, of which 13.8 million require surgery per year, globally. According to the Global Nursing and Healthcare Conference, 2016, approximately 234.0 million surgical procedures are performed globally. As per the American Society of Plastic Surgeons, around 17.5 million minimally invasive surgical procedures were performed in 2017, indicating a 2% rise from the previous year.